浙浙江医药@zju_pharma·Jul 9 RepostedRRecordati@recordati·Jul 9Recordati Industries S.p.A. (Milano, Italia). 2024 revenue ~€2.2B. Rare diseases: Carbaglu, Isturisa, Recorlev. General medicine: Lomir, Zanipress. Founded 1926. Family-controlled.11
ユユニチカ@uemFollowOur co-factor regeneration system eliminated the need for expensive NADPH.9:06:57 PM · Jul 9, 20262